Skip to Content
Søk Menu
7.-11. SEPTEMBER 2022

Følg med når vi dekker EADV 2022 | European Academy of Dermatology and Venereology

EADV 2021

How to recognize and manage hair dye allergy

  • / Annarita Antelmi

Existing and upcoming small molecules in psoriasis treatment

  • / Enikö Sonkoly
Filippa Nyberg

Sjögren’s syndrome is a common disease, but unfortunately neglected

/ Filippa Nyberg
EADV21 Play the Video
Álvaro González-Cantero

Vaccine hesitancy driven by safety concerns

/ Álvaro González-Cantero
PsoriasisCOVID-19EADV21 Play the Video

The risk of infections in psoriasis patients treated with biologics during the COVID-19 pandemic

/ Lara van der Schoot / Juul van den Reek
PsoriasisCOVID-19EADV21 Play the Video
Dimitrios Ioannides

Psoriasis has significant negative impact on quality of life

/ Dimitrios Ioannides
PsoriasisEADV21 Play the Video
Load more

Del best practice med dine kollegaer

Skriv en artikkel til BestPractice Nordic. Send et forslag til redaksjonen

Send mail til redaksjonen

MEDtalks med ledende spesialister

EADV20: Complete treatment of psoriatic disease

/ Kristian Reich
PsoriasisEADV20 Play the Video

EADV20: Baricitinib – the first JAK-inhibitor for treatment of patients with atopic dermatitis

/ Kristian Reich
Atopisk dermatittJAK-hemmereEADV20 Play the Video

EADV20: Sonelokinab – an IL-17 A/F Nanobody®, which neutralizes both IL-17A and IL-17F in patients with moderate to severe chronic plaque-type psoriasis

/ Kim Papp
PsoriasisEADV20 Play the Video

EADV20: Optimizing outcomes in moderate-to-severe atopic dermatitis

/ Lawrence Eichenfield
Atopisk dermatittEADV20 Play the Video

EADV20: Biologics increase the risk of being infected with COVID-19, but not the risk of severe disease and death

/ Giovanni Damiani
EADV20COVID-19 Play the Video

EADV20: Patienter med psoriasisgigt opnår en højere livskvalitet, når behandlingen bedrer både deres hud og ledgener

/ Lars Erik Kristensen
PsoriasisEADV20 Play the Video
Back to top